Active Studies - Center for Cancer Care & Research

When Cancer Strikes, Fight Back
If you are diagnosed with cancer, you will go to great lengths to beat it. And so do we at the Center for Cancer Care & Research. Fighting cancer is what we are all about. With experienced physicians you’ve known and trusted for years. Right in your community, not miles away. We’re affiliated with H. Lee Moffitt Cancer Center & Research Institute, which means that our patients have access to cutting edge research and treatment options. Our facility houses state-of-the-art equipment and technology – delivered with compassion from an expert team of cancer specialists. The Center for Cancer Care & Research. *Fighting for your life with the best care available.*
Support Links
	American Cancer Society
	Florida Cancer Trials
	Moffitt Cancer Center
	National Cancer Institute
	NCCN
	Oncology Nursing Society
	Support Groups

CLINICAL RESEARCH ACTIVE STUDIES

BREAST
NSABP B-43	A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
NSABP B-47	A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node Negative HER2-Low Invasive Breast Cancer
NCIC MA.32	A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer
NSMR	ASBrS Nipple Sparing Mastectomy Registry
ESOPHAGEAL
RTOG 0436	A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Who Are Treated Without Surgery
GYNECOLOGIC
GOG 0252	A Phase III Clinical Trial of Bevacizumab with IV Versus IP Chemotherapy in Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
GOG 0262	A Randomized Phase III Trial of Every-3-Weeks Paclitaxel Versus Dose Dense Weekly Paclitaxel in Combination with Carboplatin with or without Concurrent and Consolidation Bevacizumab (NSC #704865, IND #7921) in the Treatment of Primary Stage III or IV Epithelial Ovarian, Peritoneal or Fallopian Tube Cancer
MULTIPLE MYELOMA
Connect MM	The Multiple Myeloma Disease Registry
LYMPHOMA
LYM 37	Rituximab ± Bevacizumab in the Treatment of Patients with Follicular Non-Hodgkin’s Lymphoma: A Randomized, Phase II Trial
LEUKEMIA
Connect CLL	The Connect CLL Chronic Lymphocytic Leukemia Registry
LUNG
LUN 196 (TOPPS)	TOPPS: Trial Of Poor Performance Status patients. Randomized Phase II Trial of Pemetrexed vs. Pemetrexed/Bevacizumab vs. Pemetrexed/ Carboplatin/Bevacizumab in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer and ECOG Performance Status 2
ECLIPSE (LUN 201)	Randomized Phase 3 Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects with Previously Untreated Stage IV Squamous Non Small-Cell Lung Cancer (NSCLC)
PROSTATE
MCC 15008 (Green Tea)	Phase II, Randomized, Double-blind, Multi-centered Study of Polyphenon E in Men with High-grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical small acinar proliferation (ASAP)
RTOG 0815	A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer
VTE RISK
CANTARISK VTE	Registry on VTE Risk in Outpatients Starting New Chemotherapy for Cancer
RENAL
S0931	EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, a Phase III Study
MICELLANEOUS
TCC – Total Cancer Care (MCC14690)	Total Cancer Care: A Partnership with High Risk and/or Diagnosed Cancer Patients for Life
FIQCC-P03	Total Cancer Care: Florida Initiative for Quality Cancer Care Protocol (Colorectal)
FIQCC-P03	Total Cancer Care: Florida Initiative for Quality Cancer Care Protocol (Breast)

For More Information:

If you would like additional information about the Center for Research, please send your name, company or practice name, address and telephone number to the following address:

The Watson Clinic Center for Research
1600 Lakeland Hills Blvd
Lakeland, FL 33805
Attn: Noreen McGowan, BSN CCRC Administrative Coordinator
Phone 863-688-6826 · FAX 863-688-5842

Please indicate which of the following type(s) of information you would like:·

Additional information about current protocols
Center for Research grants
Contributing to Center for Research funding
Involvement in Center for Research protocols

ACTIVE STUDIES :: TARGETED THERAPIES